Clinical Trial Update: Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer

View source ↗

Summary

This completed trial evaluated the combination of Imprime PGG with cetuximab in patients with stage IV KRAS-mutated colorectal cancer, reporting on efficacy and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Imprime PGG

Snippet

Sponsor: HiberCell, Inc. | Conditions: Colorectal Cancer | Status: COMPLETED